MDS Sequencing Project Cancer Cell

ABSTRACT: Myelodysplastic syndromes (MDS) are uncommon entities, heterogeneous clinically and cytogenetically. The aim of the present study is to determine genetic alteration in this subset of patients. Expected results: Identification of new aberrations and genetic markers in order to detect novel genes involved in MDS 5q-response to Lenalidomide's treatment.

OTHER RELATED OMICS DATASETS IN: PRJNA254802

PROVIDER: EGAS00001001011 | EGA |

REPOSITORIES: EGA